Hill-Rom Holdings Inc. (NYSE:HRC) shares shot up 3.3% during mid-day trading on Wednesday . The company traded as high as $52.37 and last traded at $52.23, with a volume of 432,140 shares traded. The stock had previously closed at $50.55.

HRC has been the subject of a number of recent analyst reports. Bank of America Corp. reiterated a “buy” rating and issued a $69.00 target price on shares of Hill-Rom Holdings in a research note on Monday, May 2nd. Morgan Stanley reiterated a “hold” rating on shares of Hill-Rom Holdings in a research note on Tuesday, May 3rd. Goldman Sachs Group Inc. lifted their target price on shares of Hill-Rom Holdings from $52.00 to $55.00 in a research note on Friday, April 8th. Zacks Investment Research cut shares of Hill-Rom Holdings from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 4th. Finally, KeyCorp reiterated a “buy” rating and issued a $59.00 target price on shares of Hill-Rom Holdings in a research note on Thursday, June 23rd. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $59.83.

The firm has a market capitalization of $3.39 billion and a price-to-earnings ratio of 88.00. The company’s 50 day moving average is $50.48 and its 200 day moving average is $49.04.

Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings results on Friday, April 29th. The medical technology company reported $0.71 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.70 by $0.01. The business had revenue of $633 million for the quarter, compared to analyst estimates of $650.99 million. During the same period in the prior year, the company posted $0.64 EPS. The firm’s revenue for the quarter was up 33.2% compared to the same quarter last year. On average, equities analysts predict that Hill-Rom Holdings Inc. will post $3.27 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, June 24th. Stockholders of record on Friday, June 10th were given a dividend of $0.17 per share. The ex-dividend date was Wednesday, June 8th. This represents a $0.68 annualized dividend and a dividend yield of 1.31%.

Several hedge funds have modified their holdings of HRC. Sei Investments Co. boosted its stake in shares of Hill-Rom Holdings by 109.8% in the fourth quarter. Sei Investments Co. now owns 62,243 shares of the medical technology company’s stock valued at $2,992,000 after buying an additional 32,571 shares in the last quarter. Rhumbline Advisers raised its stake in Hill-Rom Holdings by 0.8% in the fourth quarter. Rhumbline Advisers now owns 98,850 shares of the medical technology company’s stock worth $4,751,000 after buying an additional 745 shares during the last quarter. Liberty Mutual Group Asset Management Inc. raised its stake in Hill-Rom Holdings by 51.4% in the fourth quarter. Liberty Mutual Group Asset Management Inc. now owns 36,355 shares of the medical technology company’s stock worth $1,747,000 after buying an additional 12,339 shares during the last quarter. GSA Capital Partners LLP raised its stake in Hill-Rom Holdings by 6.1% in the fourth quarter. GSA Capital Partners LLP now owns 24,630 shares of the medical technology company’s stock worth $1,184,000 after buying an additional 1,423 shares during the last quarter. Finally, Mutual of America Capital Management LLC raised its stake in Hill-Rom Holdings by 1.6% in the fourth quarter. Mutual of America Capital Management LLC now owns 38,072 shares of the medical technology company’s stock worth $1,830,000 after buying an additional 593 shares during the last quarter.

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.